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Condensation of amine 1 with aldehyde 2 gives Schiff base, N-(4-((benzofuran-2-ylmethylene) amino)phenyl)acetamide 3. Schiff
base onN-acylation with different substituted acid chlorides in the presence of triethylamine gives the corresponding benzamides,
N-acetyl-N-(4-((benzofuran-2-ylmethylene)amino)phenyl)substitutedbenzamide (NABP) 5a–j. The structures of newly syn-
thesized compounds were characterized by elemental analysis, 1HNMR, 13CNMRFT-IR, andmass spectral studies. Compounds 3
and 5a–j have been screened for their antimicrobial activity using the disc diffusion andminimum inhibitory concentration (MIC)
method against the selected bacterial and fungal strain. Compounds 5a, 5e, 5g, and 5hwere found to bemore active against all tested
strains. The antioxidant properties were evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and superoxide radical scavenging
methods. Compounds 5i and 5j showed predominant antioxidant activities among the synthesized analogues. The interaction
between NABP and bovine serum albumin (BSA) was investigated using fluorescence and ultraviolet spectroscopic techniques at
298K under imitated physiological conditions. The results revealed that NABP caused the fluorescence quenching of BSA through
a static quenching procedure.The binding constants and the number of binding sites were calculated.The binding distance between
the donor (BSA) and acceptor (NABP) was determined based on Forster’s theory.
1. Introduction
Schiff bases represent an important class of organic com-
pounds, especially in the medicinal and pharmaceutical field.
Schiff bases appear to be important intermediates in a num-
ber of enzymatic reactions involving interaction of the amino
group of an enzyme, usually that of a lysine residue, with
a carbonyl group of the substrate [1]. Schiff bases, derived
mostly from variety of heterocyclic rings, were reported to
possess a broad spectrum and a wide variety of biological
activities including antimicrobial, anti-inflammatory, anti-
convulsant, antitumor, and anti-HIV activities [2–4]. It is
evident that in azomethine derivatives the –HC=N linkage is
an essential structural requirement for biological activity.The
Schiff bases have emerged as antimicrobial agents of an
immense interest because of their broad spectrum of in-vitro
activity and their in vivo chemotherapeutic activity. In addi-
tion, benzamide derivatives which are the possible meta-
bolites of benzoxazoles show various types of biological
properties such as anthelmintic, antihistaminic, antifungal,
and antibacterial [5–7].The synthesis and characterization of
new Schiff bases related to benzamides with antibacterial and
antioxidant agents are of great importance for their potential
pharmacological use.
General investigation revealed that the components with
antimicrobial activity have gained increasing importance due
to growing worldwide concern about the increase in the rate
of infection by pathogenicmicrobes [8].This has rendered the
current available antimicrobial agents insufficient to control
microbial infections and createdmajor public health problem
[9, 10]. In addition, it is known that antifungal drugs do not
have selective activity because of the biochemical similarity
between human cell and fungi forms. Therefore, there are
many studies focused on antibacterial and antifungal com-
pounds [11–13].
Free radicals and oxygen derivatives are constantly gen-
erated in vitro by a specific metabolic process [14]. These
radicals can easily react with most biological molecules
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including proteins, lipids, lipoproteins, and DNA. These can
be responsible for wide range of human conditions, such
as arthritis, haemorrhagic shock, coronary artery diseases,
cataract, cancer, AIDS, and age-related degenerative brain
diseases [15]. Hence, there is a constant need for searching
new and effective therapeutic agents.
Proteins are the most abundant macromolecules in cells
and are crucial to maintaining normal cell functions. Bovine
serum albumin (BSA), one of the major components in
plasma protein, plays an important role in transporting and
metabolizing of many endogenous and exogenous com-
pounds in metabolism [16]. In this work, BSA was chosen as
a target proteinmolecule for studying the interaction because
of its medically important, unusual ligand-binding proper-
ties, availability, and structural homology with human serum
albumin (HSA) [17].
Based on these findings, it was of interest to synthesize a
new series of biologically active Schiff bases related to substi-
tuted benzamides and evaluate their antimicrobial studies by
disc diffusion method and antioxidant properties by DPPH
free radical scavenging and superoxide radical scavenging,
with the hope to obtain more active and less toxic synthetic
antimicrobial and antioxidant agents. In addition, the inter-
action between the NABP and BSA has been investigated
using fluorescence and UV-vis absorption spectroscopic
methods.
2. Experimental
2.1. Materials and Methods. All the chemicals and solvents
were of AR grade. Solvents were used as supplied by commer-
cial sources without any further purification. BSA (essentially
fatty-acid-free) was purchased from Sigma Aldrich Banga-
lore and stored in refrigerator at 4.0∘C. BSA solution was
prepared in the Tris-HCl buffer solution (0.05mol L−1 Tris,
0.15mol L−1 NaCl, pH 7.4) and it was kept in the dark at
298K.The compoundswere prepared as stock solutions using
DMF. All other reagents were of analytical reagent grade, and
double-distilled water was used during the experiment.
2.2. Optical Measurements. Elemental analysis (C, H, N) was
determined using a Carlo-Erba 1160 elemental analyzer. IR
spectra were recorded on a JASCO FTIR-8400 spectropho-
tometer usingNujol mulls.The 1H-NMR and 13CNMR spec-
tra were recorded on a Varian AC 400 spectrometer instru-
ment in the indicated solvent using TMS as the internal stan-
dard. Low-resolution ESI-MS spectra were obtained on aVar-
ian 1200Lmodelmass spectrometer (solvent: CH
3
OH).Melt-
ing points were determined with a Buchi 530 melting point
apparatus in open capillaries and are uncorrected. Com-
pound purity was checked by thin layer chromatographic
method (TLC) on precoated silica gel plates (Merck, Kieselgel
60 F254, layer thickness 0.25mm).Thefluorescencemeasure-
ments were performed on a fluorophotometer (Varioskan
Flash 4.00.53) and the UV-vis absorption spectra were
recorded with a UV-vis spectrophotometer (Systronics 118,
India).
2.3. Synthesis of N-(4-((benzofuran-2-ylmethylene)amino)-
phenyl)acetamide (Schiff Base) (3). Schiff base was synthe-
sized by the condensation of p-aminoacetanilide with 2-ben-
zofurancarboxaldehyde in 1 : 1 ratio. To a solution of p-amino-
acetanilide (10mmol 1.50 g) in 20mL ethanol required alde-
hyde, that is, benzofurancarboxaldehyde (10mmol 1.46 g)was
added and the reactionmixture was then stirred and refluxed
over night. The solvent was evaporated under reduced pres-
sure to obtain 2.34 g (84%) of yellow solid. 1HNMR (CDCl
3
,
𝛿 ppm): 9.07 (s, 1H, NH), 8.47 (s, 1H, –CH=N–), 7.25–7.67 (m,
9H, Ar-H), 2.20 (t, 3H, CH
3
). IR (nujol, cm−1): 1663 (C=O),









): C, 73.37; H, 5.07; N, 10.07. found: C, 73.30; H,
5.01; N, 10.02.
2.4. Synthesis of N-acetyl-N-(4-((benzofuran-2-ylmethylene)-
amino)phenyl)derivatives (5a–j). Compounds 5a–jwere pre-
pared by the reaction of compound 3 (0.01mol, 0.279 g) with





, and the reaction mixture was stirred at room tem-
perature for 20 h and the progress of the reaction was





and washed with water (50mL) and brine solution





. The crude product was obtained after
evaporation of the solvent and recrystallization from absolute
ethanol gave desired compounds 5a–j.
2.4.1. N-acetyl-N-(4-((benzofuran-2-ylmethylene)amino)phe-
nyl)-2,5-difluorobenzamide (5a). 1H NMR (CDCl
3
, 𝛿 ppm):
8.47 (s, 1H, –CH=N–), 7.26–7.67 (m, 12H, Ar-H), 2.20 (t, 3H,
CH
3
). MS, m/z: 419 (M+1). 13CNMR (DMSO-d
6
, 400MHz),
𝛿 (ppm): 27.4, 105.1, 112.7, 114.9, 118.6, 120.3, 121.3, 122.7, 122.9,
123.8, 125.3, 126.1, 126.7, 130.1, 130.4, 134.6, 135.9, 144.1, 145.6,
154.9, 158.3, 160.2, 174.1, 174.3. IR (nujol, cm−1): 1663 (C=O),










): C, 68.90; H,
3.85; N, 6.70. found: C, 68.83; H, 3.81; N, 6.65.
2.4.2. N-acetyl-N-(4-((benzofuran-2-ylmethylene)amino)phe-
nyl)-2-phenylacetamide (5b). 1HNMR (CDCl
3
, 𝛿 ppm): 8.41
(s, 1H, –CH=N–), 7.32–7.89 (m, 14H, Ar-H), 3.92 (s, 2HCH
2
),
2.21 (t, 3H, CH
3
). 13C NMR (DMSO-d
6
, 400MHz), 𝛿 (ppm):
27.4, 39.6, 105.1, 112.7, 121.4, 122.5, 122.7, 123.8, 125.3, 126.7, 128.1,
129.4, 129.8, 130.2, 130.4, 130.5, 131.3, 132.5, 134.6, 135.6, 144.1,
145.6, 155.7, 167.3, 174.1. IR (nujol, cm−1): 1650 (C=O), 1596









C, 75.74; H, 5.08; N, 7.07. found: C, 75.63; H, 5.02; N, 7.01.
2.4.3. N-acetyl-N -(4-((benzofuran-2-ylmethylene)amino)phe-
nyl)benzamide (5c). 1H NMR (CDCl
3
, 𝛿 ppm): 8.37 (s, 1H,





, 400MHz), 𝛿 (ppm): 27.4, 106.1, 112.5, 121.4,
122.7, 122.9, 123.8, 125.3, 126.1, 128.3, 128.5, 129.1, 129.3, 130.2,
130.4, 133.1, 134.5, 134.7, 135.9, 144.1, 145.1, 158.3, 174.1, 174.3. IR
(nujol, cm−1): 1658 (C=O), 1603 (C=N). MS, m/z: 383 (M+1).








): C, 75.38; H, 4.74; N, 7.33.
found: C, 75.32; H, 4.69; N, 7.30.
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2.4.4. 2-chlorobenzylacetyl(4-((benzofuran-2-ylmethylene)-
amino)phenyl)carbamate (5d). 1H NMR (CDCl
3
, 𝛿 ppm):
8.41 (s, 1H, –CH=N–), 7.36–7.86 (m, 13H, Ar-H), 4.97 (s, 2H,
CH
2
) 2.21 (t, 3H, CH
3
). 13C NMR (DMSO-d
6
, 400MHz), 𝛿
(ppm): 27.4, 62.5, 105.3, 112.5, 121.3, 122.9, 123.1, 123.8, 125.4,
126.3, 127.5, 128.9, 129.7, 129.9, 130.4, 130.6, 131.7, 134.8, 135.4,
140.2, 144.1, 145.6, 155.3, 152.7, 174.2. IR (nujol, cm−1): 1668









): C, 67.19; H, 4.29; N, 6.27. found: C, 67.12;
H, 4.18; N, 6.20.
2.4.5. N-acetyl-N-(4-((benzofuran-2-ylmethylene)amino)phe-
nyl)-4-nitrobenzamide (5e). 1H NMR (CDCl
3
, 𝛿 ppm): 8.36
(s, 1H, –CH=N–), 7.44–8.07 (m, 13H, Ar-H), 2.24 (t, 3H,
CH
3
). 13C NMR (DMSO-d
6
, 400MHz), 𝛿 (ppm): 27.4, 105.1,
112.7, 121.3, 122.7, 122.9, 123.8, 124.5, 124.7, 125.3, 126.1, 130.1,
130.3, 130.8, 131.0, 134.8, 135.4, 141.3, 144.1, 145.3, 151.3, 158.3,
174.1, 174.3. IR (nujol, cm−1): 1650 (C=O), 1603 (C=N). MS,








): C, 67.44; H,
4.01; N, 9.83. found: C, 67.42; H, 3.98; N, 9.76.
2.4.6. N-acetyl-N-(4-((benzofuran-2-ylmethylene)amino)phe-
nyl)-2-methylbenzamide (5f). 1HNMR (CDCl
3
, 𝛿 ppm): 8.39
(s, 1H, –CH=N–), 7.28–7.84 (m, 13H,Ar-H), 4.01 (s, 2H, CH
2
),
2.20 (t, 3H, CH
3
), 1.18 (s, 3H, CH
3
). 13C NMR (DMSO-d
6
,
400MHz), 𝛿 (ppm): 19.6, 27.4, 105.3, 112.5, 121.4, 122.8, 123.0,
124.1, 125.7, 126.0, 128.1, 129.2, 130.5, 130.7, 131.8, 133.0, 134.5,
135.1, 136.4, 138.2, 144.4, 145.9, 158.1, 174.1, 174.3. IR (nujol,









): C, 75.74; H, 5.08; N, 7.07. Found: C, 75.69;
H, 5.01; N, 7.04.
2.4.7. N-acetyl-N-(4-(benzofuran-2-ylmethyleneamino)phe-
nyl)-3,4,5-trifluorobenzamide (5g). 1H NMR (CDCl
3
, 𝛿
ppm): 8.39 (s, 1H, –CH=N–), 7.29–7.63 (m, 11H, Ar-H), 2.21 (t,
3H, CH
3
). 13C NMR (DMSO-d
6
, 400MHz), 𝛿 (ppm): 27.3,
105.2, 110.4, 110.7, 112.9, 121.7, 122.7, 122.9, 124.3, 124.9, 125.4,
130.2, 130.4, 133.4, 134.6, 135.2, 144.1, 144.3, 145.6, 158.1, 160.7,
160.9, 174.1, 174.3. IR (nujol, cm−1): 1655 (C=O), 1601 (C=N).











66.06; H, 3.46; N, 6.42. Found: C, 66.01; H, 3.42; N, 6.40.
2.4.8. N-acetyl-N-(4-((benzofuran-2-ylmethylene)amino)phe-
nyl)-3,5-difluorobenzamide (5h). 1H NMR (CDCl
3
, 𝛿 ppm):
8.49 (s, 1H, –CH=N–), 7.45–7.73 (m, 12H, Ar-H), 2.20 (t, 3H,
CH
3
). 13C NMR (DMSO-d
6
, 400MHz), 𝛿 (ppm): 27.4, 105.1,
109.3, 110.4, 110.6, 112.7, 121.3, 122.9, 123.1, 124.1, 125.37, 126.0,
130.6, 130.8, 134.6, 135.4, 138.7, 144.2, 145.3, 158.3, 162.0, 162.3,
174.2, 174.5. IR (nujol, cm−1): 1662 (C=O), 1597 (C=N). MS,











H, 3.85; N, 6.70. found: C, 68.81; H, 3.80; N, 6.65.
2.4.9. N-acetyl-N-(4-(benzofuran-2-ylmethyleneamino)phe-
nyl)-4-methoxybenzamide (5i). 1H NMR (CDCl
3
, 𝛿 ppm):,
8.81 (s, 1H, –CH=N–), 7.51–7.76 (m, 13H, Ar-H), 3.86 (s, 3H,
OCH
3
), 2.25 (t, 3H, CH
3
). 13C NMR (DMSO-d
6
, 400MHz),
𝛿 (ppm): 27.3, 57.9, 105.3, 112.5, 115.1, 115.3, 121.3, 122.7, 122.9,
124.3, 124.9, 125.4, 127.7, 129.3, 129.5, 130.1, 130.3, 134.6, 135.2,
142.4, 146.9, 158.3, 167.0, 174.1, 174.3. IR (nujol, cm−1): 1658















10.02 (s, 1H, OH), 8.32 (s, 1H, –CH=N–), 7.56–8.07 (m, 13H,
Ar-H), 2.23 (t, 3H, CH
3
). 13C NMR (DMSO-d
6
, 400MHz),
𝛿 (ppm): 27.3, 105.7, 112.1, 117.4, 117.6, 121.9, 122.7, 122.9, 124.3,
125.1, 125.4, 127.3, 129.4, 129.6, 130.1, 130.3, 134.6, 135.3, 144.4,
146.2, 158.7, 163.9, 174.7, 174.9. IR (nujol, cm−1): 3434 (OH),









): C, 72.35; H, 4.55; N, 7.03. found: C, 72.30;
H, 4.52; N, 7.01.
2.5. Antimicrobial Activity
2.5.1. Microbial Strains. The in vitro antimicrobial screening
effects of the compounds (3 and 5a–j)were individually tested
against a panel of bacteria and fungi including Staphylococcus
aureus (NCIM 5021), Bacillus subtilis (NCIM 2999), Pseu-
domonas aeruginosa (NCIM 5029), Escherichia coli (NCIM
2574), Candida. albicans (NCIM 3471), and Aspergillus flavus
(NCIM 524). Microbial strains were cultured overnight at
37∘C in nutrient and potato dextrose agar medium. All the
puremicrobial strainswere obtained fromNational Chemical
Laboratory (NCL), Pune, India.
2.5.2. Antimicrobial Screening. The antibacterial activity of
compounds was determined by agar disc diffusion method
[18]. Briefly, a suspension of tested bacterial strainswas spread
on the nutrient agar medium and potato dextrose agar for
fungi. The discs (6mm in diameter) impregnated with test
chemicals each dissolved in concentration (100 𝜇g/mL in
DMSO) were placed on the inoculated agar and these plates
were kept at 4∘C for 2 h. The plate was incubated at 37∘C for
24 h in case of bacteria and 48 h at 28∘C in case of fungi.
streptomycin (10 𝜇g/disc) and fluconazole (10𝜇g/disc) were
used as the standards for antibacterial and antifungal activity,
respectively. All the samples were performed in triplicate and
the zone of inhibition was measured in millimeters.
2.5.3. Minimum Inhibitory Concentration (MIC). The mini-
mum inhibitory concentration of the synthesized compounds
was determined by dilution method [19]. The compounds
were dissolved and then diluted using DMSO; two-fold serial
concentrations of the compounds were employed to deter-
mine the MIC. In this method, the test concentrations of
chemically synthesized compounds were made from 5 to
125 𝜇g/mL.TheMIC value was determined as the lowest con-
centration of the compound that completely inhibitedmacro-
scopic growth of microorganism.
2.6. Antioxidant Activity
2.6.1. DPPH Free Radical Scavenging Activity. The capacity to
scavenge the stable free radical 2,2-diphenyl-1-picrylhydrazyl
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(DPPH) was monitored according to the Blois method [20].
The test samples (10–100 𝜇L) were mixed with 1mL of DPPH
(0.1mM) solution and filled up with methanol to a final vol-
ume of 4mL. Absorbance of the resulting solution was mea-
sured at 517 nm in a visible spectrophotometer (Model 166,
Systronics, India).The free radical scavenging rate of the reac-
tion solution was calculated as a percentage (%) of DPPH de-
colouration using the equation
I (%) = (
𝐴blank − 𝐴 sample
𝐴blank
) × 100, (1)
where 𝐴blank is the absorbance of the control reaction mix-
ture excluding the test compounds, and𝐴 sample is the absorb-
ance of the test compounds. Radical scavenging potential was
expressed as IC
50
value, which represents the sample concen-
tration at which 50% of the DPPH radicals were scavenged.
Testswere carried out in triplicate and the results were expres-
sed as mean values ± standard deviations.
2.6.2. Superoxide Radical Scavenging Assay. Superoxide radi-
cal scavenging activity was measured as described by Kovala-
Demertzi et al., (2004) [21]. The assay is based on the reduc-
tion of nitroblue tetrazolium (NBT) by superoxide ions gen-
erated by the xanthine-xanthine oxidase system (X–XO).The
reaction system contained 0.2mM xanthine and 0.6mM
NBT in 0.1Mphosphate buffer, pH 7.8.The tested compounds
were dissolved inmethanol.The reaction was started by addi-
tion of XO (0.07UmL−1), an activity which allowed to yield
the absorbance change between 0.03 and 0.04 per minute, at
560 nm. The extent of NBT reduction was followed spectro-
photometrically, bymeasuring the increase of the absorbance
at 560 nm. All the experiments were replicated three times.
The IC
50
of each compound was defined as the concentration
which inhibited 50% of the NBT reduction by O
2
∙− produced
in the X–XO system.
2.7. Measurement of Binding Parameters. For each of the four
active compounds (5a, 5c, 5g, 5h, 5i, and 5j), the binding
parameters with BSA molecules were measured by fluores-
cence spectroscopy. A solution (2.5mL) containing 1.00 ×
10−5mol L−1 BSA was titrated by successive additions of 1.00
× 10−3mol L−1 NABP stock solution and the concentration of
NABP varied from 0 to 3.0 × 10−5mol L−1 (a–g). Titrations
were done manually by using microinjector. Fluorescence
intensity was measured (excitation at 280 nm and emission
at 340 nm). All experiments were performed at 298K.
3. Results and Discussion
3.1. Chemistry. The synthetic route for the preparation of
benzamide compounds is outlined in Scheme 1. Synthesis
of the desired compound 3 was achieved by condensation
of p-aminoacetanilide 1 with 2-benzofurancaroxaldehyde 2
according to the known method [22]. The second synthetic
step involves the amidation of compound 3 with different
substituted acid chlorides (4a–j) in presence of triethylamine
in dichloromethane giving rise to the respective aryl amide
Table 1: Physical and chemical properties of compounds 5a–j.
























5i H3CO 80 205
5j HO 83 213
derivatives (5a–j). The compounds were purified by repeated
recrystallization from ethanol and then dried. The physical
and chemical properties of all the synthesized compounds
are given in Table 1. The elemental analyses, 1H NMR, 13C
NMR, and FTIR spectra are fully consistentwith the structure
and the melting points are sharp, indicating the purity of the
prepared Schiff bases.
In the 1HNMR spectra, the chemical shift and multiplic-
ity patterns correlated well with the proposed structures. The
formation of compound 3 was supported by the 1H NMR
spectrum (see Supplementary Material available online at
http://dx.doi.org/10.1155/2013/791591) by the appearance of



























Scheme 1: Synthetic route of amide derivatives 5a–j.
a sharp singlet at 8.47 ppm, corresponding to the azome-
thine (–CH=N–) proton. The multisignals within the range
7.25–8.07 ppm are assigned to the aromatic protons. 1H
NMR spectra of all synthesized compounds (5a–j) showed
–CH=N– proton as singlet at 8.32–8.81 ppm. A comparison
of 1HNMR spectra of compounds 5a–jwith the 3 has shown
disappearance of signal of NH (9.07 ppm) proton on the
formation of amide bond.The signal due to –OH in the com-
pound 5j appeared as singlet at 10.02 ppm. The aromatic
protons were observed at expected regions. 1HNMR spectra




The absence of NH
2
and C=O absorption bands in the
IR spectra confirmed that the synthesized compounds were
obtained via condensation.The IR spectrum showed a chara-
cteristic strong absorption band at 1603 cm−1 which is attri-
buted to the stretching vibration of C=N bond formation in
the synthesized compound 3. The IR spectra of 5a–j revealed
the presence of C=O stretching band at 1650–1668 cm−1 in
all the analogues and 5j showed broad phenolic stretching at
3434 cm−1. Mass spectra of all newly synthesized compounds
showed M+1 peak, in agreement with their molecular for-
mula.
3.2. Antimicrobial Activity. In testing the antibacterial and
antifungal activity of these compounds, more than one test
organism was used to increase the chance of detecting antibi-
otic principles in tested materials. The antimicrobial activity
of the newly synthesized compounds (5a–j) was evaluated
against two gram-positive bacteria (B. subtilis and S. aureus),
two gram-negative bacteria (E. coli and P. aeruginosa), and
two fungi (A. niger and A. flavus). Minimum inhibitory con-
centration (MIC) of these compounds against bacteria and
fungi was determined. Standard antibiotics, namely, strepto-
mycin and standard antifungal drug fluconazole were used
for comparison with antibacterial and antifungal activities
shown by compounds (Table 2). All the compounds pos-
sessed moderate to good antibacterial activity.
The obtained compounds display good antibacterial
activity. In case of antibacterial activity, all the compounds
possess higher antibacterial activity than the compound 3.
Themost potent antibacterial activity exhibited by compound
5g (MIC 9.8 𝜇g/mL) with three fluoro groups substituted ring
in the respective series compared to the compounds bearing
other electron-donating or -withdrawing groups. The com-
pounds 5a and 5h possess active inhibition against all the
tested strains; this may be due to the fact that the presence
of two fluoro groups in the compound is responsible for the
enhancement of activity. Other compounds exhibit moderate
to good antibacterial activity against all organisms. Among
these compounds, 5b and 5f exhibit poor antibacterial activ-
ity against S. aureus, E. coli, and P. aeruginosa as compared to
the standard drug.
The screening data of antifungal activity of these series of
compounds showswide range of antifungal activity. Similarly,
compounds 5a, 5e, 5g, and 5h exhibit good antifungal activity
against Candida albicans and Aspergillus flavus compared to
the standard drug fluconazole. In thewhole series, compound
5g with MIC 10 𝜇g/mL shows the highest percentage of
inhibition against both fungal strains and the compounds 5a
and 5h pose difference in activity due to presence of fluoro
group at different positions. It is interesting to note that the
electron-withdrawing property of the phenyl ring is impor-
tant, which is corroborated by eminent activity of compounds
with halogen group and decreased activity of compounds
with either hydroxyl, methyl, or methoxy group in the phenyl
ring; hence the replacement of electron-donating group in
place of halogens shows decrease in antimicrobial activity.
The researches of structure-activity relationship show that
halogen atoms on phenyl ring enhanced the biological activ-
ity effectively [23]. It is because halogen could improve the
affinity between compounds and special target of bacteria.
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Table 2: Antibacterial and antifungal activity of the synthesized compounds 3 and 5a–j.
Compounds
In vitro activity zone of inhibition in mm (MIC in 𝜇g/mL)a
Gram positive Gram negative Fungi
S. aureus B. subtilis E. coli P. aeruginosa A. niger A. flavus
3 08 (75) 07 (75) 11 (>100) 10 (>100) 12.4 (75) 12.5 (75)
5a 11 (12) 16 (12) 12 (25) 14 (25) 11 (15) 10.4 (15)
5b 10 (50) 10 (30) 10 (50) 11 (30) 12 (25) 15 (25)
5c 11 (35) 10 (35) 15 (50) 12 (50) 09 (40) 15 (40)
5d 12 (30) 14 (50) 10 (50) 13 (50) 13.7 (25) 11 (40)
5e 14 (15) 11 (15) 09 (25) 11 (25) 14.1 (20) 13.6 (20)
5f 10 (50) 08 (50) 11 (100) 10 (100) 12 (100) 10.2 (75)
5g 13.6 (9.8) 13.5 (10) 12.7 (12) 14.0 (10) 13.2 (10) 14.0 (15)
5h 14 (12.4) 12 (12.4) 11 (25) 17 (25) 11.4 (10) 10.9 (15)
5i 14 (40) 10 (50) 11 (30) 13 (35) 10 (35) 14 (30)
5j 12 (35) 09 (35) 11 (50) 13 (50) 09 (40) 15 (40)
Streptomycin 14.1 (05) 13.4 (05) 16.5 (05) 14 (05) — —
Fluconazole — — — — 16 (05) 19 (05)
aAverage of three replicates.
3.3. Antioxidant Activity. DPPH radical scavenging activity
evaluation is a standard assay in antioxidant activity studies
and offers a rapid technique for screening the radical scav-
enging activity of specific compounds [24]. The free radical
scavenging activity of newly synthesized compounds was
tested by their ability to bleach the stable radical DPPH. The
activity was monitored by following the absorption at 517 nm
in a visible spectrophotometer. In the presence of any free
radical scavenger, this odd electron pairs up and causes the
diminishing of absorption band which is proportional to the
number of electrons taken up.The activity was studied at dif-
ferent concentrations for each compound. A freshly prepared
DPPH solution exhibits a deep purple color with an absorp-
tion maximum at 517 nm. Resulting from a color change
from purple to yellow the absorbance decreased when the
antioxidant molecule can quench DPPH free radical through
donation of hydrogen atom or by electron donating to form
a stable DPPH molecule [25]. Hence, more rapidly the
absorbance decreases, the more potent the antioxidant activ-
ity of the compound becomes.
The scavenging effect of the synthesized compounds was
reported in Table 3. All the compounds (5a–j) showed com-
parable or slightly less activity to the standard ascorbic acid.
The antioxidant activity was expressed as the 50% inhibitory
concentration (IC
50
) based on the amount of compound
required for a 50% decrease of the initial DPPH radical con-
centration. It was observed that the entire compounds
notably reduced the concentration of DPPH free radical. It is
clearly demonstrated that free radical scavenging increases
with increasing concentration.
Thebetter activity of compound 5j (IC
50
15.3± 0.11 𝜇g/mL),
having hydroxyl group at p-position in the aromatic ring, has
high electron-releasing properties and it activates aromatic
ring. The compound 5i (IC
50
18.5 ± 0.17 𝜇g/mL), bearing an
electron-donating methoxy group at para position, showed
the better DPPH radical scavenging activity compared to
electron-withdrawing group substituted to phenyl ring. The
compounds 5g and 5h (IC
50
> 100 𝜇g/mL) exhibit less
activity than that of standard and 5j, due to the presence
of electron-withdrawing group. Observing the overall data
for antioxidant activity, it is clear that compounds 5i and 5j
were found to be the most effective antioxidants among all
compounds.
Superoxide anion radical is normally initially formed, and
its effects can bemagnified because it produces other kinds of
free radicals and oxidizing agents [26]. The enzymatic super-
oxide anion radical was generated by the xanthine/xanthine
oxidase reaction system. The production of superoxide was
estimated by the nitroblue tetrazolium method [27]. The
results (Table 3) revealed that all of the tested compounds
exhibited superoxide activity with IC
50
in the range of 11.6–
123 𝜇g/mL. It should be noted that the activity of the com-
pounds 5i and 5j was comparable to that of BHA as observed
from the IC
50
values. Compounds 5i and 5j showed very good
activity, since these compounds are having methoxy and
hydroxyl groups at p-position in the ring, respectively. Dif-
ferently, in them-position, methoxy and hydroxyl groups act
as an electron-withdrawing properties, (positive mesomeric
effect is higher than negative inductive effect), which are
possible for providing a destabilizing effect [28, 29].
3.4. Fluorescence Quenching of BSA by NABP. Fluorescence
spectroscopy is a powerful tool for the study of the reactivity
of chemical and biological systems since it allows nonintru-
sive measurements of substances in low concentration under
physiological conditions [30]. Fluorescence quenching refers
to any process which decreases the fluorescence intensity of
a sample induced by a variety of molecular interactions with
quencher molecule, including excited-state reactions, molec-
ular rearrangements, energy transfer, ground-state complex
formation, and collisional quenching processes.
The fluorescence spectra of BSA in the presence of dif-
ferent concentrations of NABP are shown in Figure 1. It is
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well known that BSA emits a strong fluorescence peaked
at around 340 nm with excitation wavelength of 280 nm.
Viewed from Figure 1, the presence of NABP led the emission
intensity of BSA to decrease regularly, which indicated
that the NABP can interact with BSA and quenches its
intrinsic fluorescence. A remarkable red shift of BSA fluo-
rescence emission maximum wavelength is observed in 5c,
5j, and 5h. Red shift observed upon interaction of BSA
with the compounds 5c, 5j, and 5h indicates that change
in conformation of tryptophan environment in BSA. The
polarity around the tryptophan residue increases whereas
its hydrophobicity decreases [31]. Furthermore, a slight blue
shift of the maximum emission wavelength was observed
for 5a, 5g, and 5i. The phenomena imply that the polarity
around the tryptophan residue decreases with the increasing
hydrophobicity after addition of 5a, 5g, and 5i to BSA.
3.5. Fluorescence Quenching Mechanism: Identification of
Binding Site and Binding Constant. In order to investigate the
quenching mechanism, the fluorescence quenching data 𝐾
0




= 1 + 𝐾sv [𝑄] = 1 + 𝐾𝑞𝜏0 [𝑄] , (2)
where 𝐹
0
and 𝐹 denote the steady-state fluorescence intensi-
ties in the absence and in the presence of quencher, respec-
tively, 𝐾
0
is binding constant of BSA, [𝑄] is the equilibrium
concentration of the quencher, and 𝑛 is the number of
binding sites.The average lifetime, 𝜏
0
of themolecule without
quencher is 10−8 s [33].
The Stern-Volmer plots for the interaction of compound
with BSA at temperature (𝑇 = 298K) are shown in Figure 2.
In all cases the plots are fairly linear. From Figure 2, the
values of 𝐾sv and 𝐾𝑞 were obtained and listed in Table 4.
Dynamic and static quenching can be distinguished by the
quenching constant 𝐾
𝑞
[34]. The observed values of 𝐾
𝑞
were larger than themaximum scattering collision quenching
constant 2.0 × 1010 Lmol−1 s−1, which suggests that the fluo-
rescence quenching mechanism between NABP and BSA
may be static rather than dynamic [35].
When the quenching mechanism is static, the binding







= log 𝐾a + 𝑛 log [𝑄] . (3)
The plot of log[(𝐹
0
− 𝐹)/𝐹] versus log[NABP], binding
constant 𝐾a, and binding sites 𝑛 were calculated from the
intercept and slope. Figure 2 shows the log[(𝐹
0
−𝐹)/𝐹] versus
log[NABP] and Table 5 gives the corresponding calculated
results. The value of n approximately equaled 1.
The substitutions on the benzene ring could enhance the
binding affinity of BSA and NABP. As shown in Table 5, the
binding constants of the interaction between them increased
in the following order: 5j < 5c < 5h < 5g < 5a < 5i.The two
aspects that may result in binding potency are as follows:
(1) the process of NABP-BSA binding is promoted strongly by
Table 3: DPPH radical scavenging activity of compounds (5a–j).
Compound IC50 (𝜇g/mL)
DPPH Superoxide
3 95.3 ± 0.76 85.1 ± 0.33
5a 97.5 ± 0.37 91.3 ± 0.26
5b 85.3 ± 0.14 92.0 ± 0.35
5c 61.7 ± 0.55 60.9 ± 0.28
5d 48.9 ± 0.11 55.3 ± 0.04
5e 87.4 ± 0.31 79.2 ± 0.24
5f 53 ± 0.04 49 ± 0.17
5g >125 123 ± 0.44
5h 100 ± 0.19 96.1 ± 0.31
5i 18.5 ± 0.17 14.3 ± 0.23
5j 15.3 ± 0.11 11.6 ± 0.04
AAa 12.6 ± 0.43 Ntc
BHAb Ntc 13.4 ± 0.29
aAscorbic acid, bbutylated hydroxyanisole.
cNot tested.





5a 9.96 × 104 9.96 × 1012 0.9981
5c 1.93 × 104 1.93 × 1012 0.9987
5g 7.98 × 104 7.98 × 1012 0.9978
5h 2.13 × 104 2.13 × 1012 0.9974
5i 7.40 × 104 7.40 × 1012 0.9994
5j 2.39 × 104 2.39 × 1012 0.9972
aLinear quotient.




5a 5.26 × 105 1.180 0.9981
5c 2.59 × 104 0.855 0.9987
5g 1.57 × 105 1.281 0.9998
5h 0.79 × 105 1.136 0.9991
5i 6.38 × 105 1.208 0.9996
5j 1.09 × 104 0.961 0.9970
the polarity of the substituent; (2) themolecular size ofNABP,
the large-size molecule, may have larger hydrophobic area
which can interact with hydrophobic surface on the protein
molecule. In this work, the molecular size and polarity play a
significant role in the binding between NABP and BSA.
3.6. Energy Transfer from BSA to Compound. The overlap of
the UV absorption spectra of NABP with the fluorescence
emission spectra of BSA is shown in Figure 3.
The binding distance (𝑟) between a protein residue
(donor) and a bound drug molecule (acceptor) can be
calculated from Foster’s nonradiative energy transfer theory.
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Figure 1: Fluorescence quenching spectra of BSA by NABP (5a, 5c, 5g, 5h, 5i, 5j) at 298K. c(BSA) = 1.00 × 10−5mol L−1; c(NABP): 0, 0.5, 1.0,
1.5, 2.0, 2.5, 3.0 (×10−5mol L−1) from a to g, respectively.
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Figure 2: Van’t Hoff ’s plots for the interaction of BSA and NABP.
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Figure 3: The overlap of the fluorescence spectrum of BSA (i) and the absorbance spectrum of NABP (ii).
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The efficiency of energy transfer 𝐸 and the distance between
the acceptor and donor 𝑟 can be defined as the following
equation [36]:













where 𝑟 is the distance between the acceptor and donor;𝐹 and
𝐹
0
are the fluorescence intensities of BSA in the presence of
and in the absence of quencher, respectively; 𝑅
0
is the critical
energy transfer distance when the transfer efficiency is 50%.












2 is a factor describing the spatial orientation factor
related to the geometry of the donor and acceptor of dipoles;
𝑁 is the refractive index of medium; Φ is the fluorescence
quantum yield of the donor in the absence of acceptor; 𝐽 is the
effect of spectra overlap between the fluorescence emission
spectrum of the donor and the UV-vis absorption spectrum
of the acceptor, and 𝐽 can be calculated by (6):
𝐽 =





where 𝐹(𝜆) is the corrected fluorescence intensity of the
donor in thewavelength range from𝜆 to 𝜆+Δ𝜆 and 𝜀(𝜆) is the
molar absorption coefficient of the acceptor at wavelength 𝜆.
In the present case, 𝐾2 = 2/3, 𝑁 = 1.311, and Φ = 0.118
for BSA molecules [37], respectively. And then, the values
of 𝐽, 𝐸, 𝑅
0
, and 𝑟 were calculated and shown in Table 6. The
binding distance is shorter than 8 nmwhich indicates that the
energy could transfer from BSA to NABP with high possi-
bility [38].
4. Conclusion
In this work, we have presented the synthesis of novel ben-
zamides related to Schiff base in good yield and their spectro-
scopic characterization by means of different spectral studies
and their antimicrobial and antioxidant activities have been
evaluated. The antimicrobial evaluation data revealed that
among the compounds studied, derivatives 5a, 5e, 5g, and
5h have exhibited good antibacterial activity comparable to
the standard streptomycin, while compounds 5a, 5g, and 5h
displayed better antifungal activity comparable to the stand-
ard fluconazole. The maximum activity was observed with
compounds having trifluoro substituent in the phenylmoiety.
Further, the compounds 5i and 5j displayed pronounced
antioxidant activity as interpreted by the results of DPPH and
superoxide radical scavenging assays.The possible quenching
mechanism of fluorescence of BSA by NABP was a static
quenching by forming the BSA-NABP complexes. All the
substituents can influence the binding affinity of NABP with
BSA. The effect of 3,4,5-trifluoro, 4-OCH
3
, 2,5-difluoro, and
3,5-difluoro on the benzene ring enhances the binding affinity
of NABP with BSA. According to Forster’s theory of nonra-
diation energy transfer, energy transfer from BSA to NABP
occurs with high probability.
Table 6: The distance parameters between compounds and BSA.
Compound 𝐽 (cm3 Lmol−1) 𝑅
0
(nm) 𝐸 𝑟 (nm)
5a 1.05 × 10−14 2.51 0.11 3.77
5c 3.05 × 10−14 3.04 0.14 4.11
5g 2.37 × 10−14 2.86 0.31 3.07
5h 4.91 × 10−14 2.16 0.15 2.93
5i 2.79 × 10−14 2.83 0.33 3.17
5j 4.26 × 10−14 3.02 0.14 4.09
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